127
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

Glittre activities of daily living test is reliable and valid in hemodialysis patients

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 542-548 | Received 13 Jul 2021, Accepted 10 Jan 2022, Published online: 12 Feb 2022

References

  • Painter P. Physical functioning in end-stage renal disease patients: update 2005. Hemodial Int. 2005;9(3):218–235.
  • Garcia RSA, Lucinda LMF, Ramos FA, et al. Factors associated with functional capacity in hemodialysis patients. Artif Organs. 2017;41(12):1121–1126.
  • Painter P, Roshanravan B. The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22(6):615–623.
  • Roshanravan B, Robinson-Cohen C, Patel KV, et al. Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol. 2013;24(5):822–830.
  • Segura-Ortí E, Gordon PL, Doyle JW, et al. Correlates of physical functioning and performance across the spectrum of kidney function. Clin Nurs Res. 2018;27(5):579–596.
  • Flisinski M, Brymora A, Elminowska-Wenda G, et al. Morphometric analysis of muscle fibre types in rat locomotor and postural skeletal muscles in different stages of chronic kidney disease. J Physiol Pharmacol. 2014;65(4):567–576.
  • Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352.
  • Sheshadri A, Kittiskulnam P, Johansen KL. Higher physical activity is associated with less fatigue and insomnia among patients on hemodialysis. Kidney Int Rep. 2019;4(2):285–292.
  • Leal DV, Ferreira A, Watson EL, et al. Muscle-bone crosstalk in chronic kidney disease: the potential modulatory effects of exercise. Calcif Tissue Int. 2021;108(4):461–475.
  • More KM, Blanchard C, Theou O, et al. A location-based objective assessment of physical activity and sedentary behavior in ambulatory hemodialysis patients. Can J Kidney Health Dis. 2019;6:1–10.
  • Stack AG, Molony DA, Rives T, et al. Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis. 2005;45(4):690–701.
  • Watanabe T, Kutsuna T, Suzuki Y, et al. Perceived difficulty in activities of daily living and survival in patients receiving maintenance hemodialysis. Int Urol Nephrol. 2021;53(1):177–184.
  • Painter P, Marcus RL. Assessing physical function and physical activity in patients with CKD. Clin J Am Soc Nephrol. 2013;8(5):861–872.
  • Montemezzo D, Pereira DAG, Ribeiro-Samora GA, et al. Comparação das respostas fisiológicas do incremental shuttle walk test e do Glittre-ADL test: instrumentos complementares Para avaliação da capacidade funcional. Fisioter Pesqui. 2020;27(1):57–63.
  • Skumlien S, Hagelund T, Bjørtuft Ø, et al. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med. 2006;100(2):316–323.
  • Reis CMd, Silva TCd, Karloh M, et al. Performance of healthy adult subjects in glittre ADL-test. Fisioter e Pesqui. 2015;22(1):41–47.
  • Fernandes-Andrade AA, Britto RR, Soares DCM, et al. Evaluation of the Glittre-ADL test as an instrument for classifying functional capacity of individuals with cardiovascular diseases. Braz J Phys Ther. 2017;21(5):321–328.
  • José A, Dal Corso S. Reproducibility of the six-minute walk test and glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease. Braz J Phys Ther. 2015;19(3):235–242.
  • Santos K, Gulart AA, Munari AB, et al. Reproducibility of ventilatory parameters, dynamic hyperinflation, and performance in the Glittre-ADL test in COPD patients. COPD. 2016;13(6):700–705.
  • Monteiro F, Ponce DAN, Silva H, et al. Validity and reproducibility of the glittre ADL-test in obese and post-bariatric surgery patients. Obes Surg. 2017;27(1):110–114.
  • Silva DDO, Corrêa JCF, de Sá MAF, et al. Validation and reproducibility of the glittre activities of daily living test for individuals with Parkinson’s disease. Rev Neurol. 2019;69(10):395–401.
  • Šerbetar I. Određivanje nekih mjera apsolutne i relativne pouzdanosti motoričkih testova. Croat J Educ. 2015;17(1):37–48.
  • Weir JP. Quantifying test–retest reliability using the intraclass correlation coefficient and the SEM. J Strength Condition Res. 2005;19(1):231–240.
  • Figueiredo PHS, Silva ACR, Costa HS, et al. The glittre activities of daily living as a potential test for functional evaluation of patients on hemodialysis: a validation study. Disabil Rehabil. 2020;1:1–8.
  • Jones NL, Killian KJ. Exercise limitation in health and disease. N Engl J Med. 2000;343(9):632–641.
  • Kohn MA, Senyak J. No title sample size calculators [Internet]. UCSF CTSI; 2020. Available from: https://www.sample-size.net/
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163.
  • Kuipers J, Usvyat LA, Oosterhuis JK, et al. Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients. Am J Kidney Dis. 2013;62(4):779–788.
  • Migueles JH, Cadenas-Sanchez C, Ekelund U, et al. Accelerometer data collection and processing criteria to assess physical activity and other outcomes: a systematic review and practical considerations. Sports Med. 2017;47(9):1821–1845.
  • Reis CMd, Karloh M, Fonseca FR, et al. Functional capacity measurement: reference equations for the glittre activities of daily living test. J Bras Pneumol. 2018;44(5):370–377.
  • Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381.
  • Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001;37(1):153–156.
  • Portney LG, Watkins MP. Validity of measurements. In: Foundations of clinical research applications to practice. 3rd ed. New Jersey: Pearson; 2008.
  • Vet HCWd, Terwee CB, Mokkink LB, et al. Concepts, theories and models, and types of measurements. In: Measurement in medicine: a practical guide (practical guides to biostatistics and epidemiology). Cambridge: Cambridge University Press; 2011. p. 7–29.
  • Matsuzawa R, Roshanravan B, Shimoda T, et al. Physical activity dose for hemodialysis patients: where to begin? Results from a prospective cohort study. J Ren Nutr. 2018;28(1):45–53.
  • World Health Organization. Global recommendations on physical activity for health; 2010. Available from: https://www.who.int/publications/i/item/9789241599979
  • Karloh M, Araujo CLP, Gulart AA, et al. The Glittre-ADL test reflects functional performance measured by physical activities of daily living in patients with chronic obstructive pulmonary disease. Braz J Phys Ther. 2016;20(3):223–230.
  • Gulart AA, Araujo CLPd, Munari AB, et al. The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease. Braz J Phys Ther. 2020;24(1):54–60.
  • Johansen KL, Kaysen GA, Dalrymple LS, et al. Association of physical activity with survival among ambulatory patients on dialysis: the comprehensive dialysis study. Clin J Am Soc Nephrol. 2013;8(2):248–253.
  • Bruton A, Conway JH, Holgate ST. Reliability: what is it, and how is it measured? Physiotherapy. 2000;86(2):94–99.
  • Knak KL, Andersen LK, Witting N, et al. Reliability of the 2- and 6-minute walk tests in neuromuscular diseases. J Rehabil Med. 2017;49(4):362–366.
  • Arena R, Myers J, Williams MA, et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation. 2007;116(3):329–343.
  • Tufanin A, Souza GF, Tisi GR, et al. Cardiac, ventilatory, and metabolic adjustments in chronic obstructive pulmonary disease patients during the performance of glittre activities of daily living test. Chron Respir Dis. 2014;11(4):247–255.
  • Stenvinkel P, Carrero JJ, Von Walden F, et al. Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. Nephrol Dial Transplant. 2016;31(7):1070–1077.
  • Sabatino A, Cuppari L, Stenvinkel P, et al. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021;34(4):1347–1372.
  • Ribeiro HS, Wilund KR, Lima RM. COVID-19 quarantine in chronic kidney disease patients: a focus on sarcopenia traits. Braz J Nephrol. 2021;43:293–294.
  • Li J. Rehabilitation management of patients with COVID-19: lessons learned from the first experience in China. Eur J Phys Rehabil Med. 2020;56(3):335–338.
  • Silver SA, Adu D, Agarwal S, et al. Strategies to enhance rehabilitation after acute kidney injury in the developing world. Kidney Int Rep. 2017;2(4):579–593.
  • Ortiz A, Cozzolino M, Duivenvoorden R, et al. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87–94.
  • Fassbinder TRC, Winkelmann ER, Schneider J, et al. Functional capacity and quality of life in patients with chronic kidney disease in pre-dialytic treatment and on hemodialysis – a cross sectional study. J Bras Nefrol. 2015;37(1):47–54.
  • Larkin JW, Han M, Han H, et al. Impact of hemodialysis and post-dialysis period on granular activity levels. BMC Nephrol. 2020;21(1):1–17.
  • Gulart AA, Munari AB, Klein SR, et al. The Glittre-ADL test cut-off point to discriminate abnormal functional capacity in patients with COPD. COPD. 2018;15(1):73–78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.